Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Global acquisition brings together health brands

5 January 2004

Deal successfully closed and Roche Consumer Health business now integrated

Global acquisition brings together leading health brands

Division ranks among the top three global OTC players – Berocca®, Elevit®, Bepanthen®, and Redoxon® and are now in the Bayer family of brands

Auckland – Some of New Zealand’s leading health care brands will be combined under one company following Bayer’s closure of its global acquisition of Roche Consumer Health. From January onwards, the Roche Consumer Health business will become part of the Bayer HealthCare Consumer Care Division, turning Bayer into a leading global over-the-counter (OTC) consumer health organisation.

In New Zealand, Bayer’s Consumer Care Division will nearly double its brand portfolio with the addition of market leading products such as Berocca®, Elevit® and Bepanthen®. The new products will compliment Bayer’s existing trusted brands such as Aspirin®, Canesten® and Pluravit®, and produce combined New Zealand sales of more than $10.5 million.

Bayer HealthCare’s Managing Director for Australia and New Zealand Derrill Palidwar said the acquisition meant significant growth for Bayer’s consumer care business in New Zealand.

“We have created eight new consumer care positions in New Zealand as a result of the acquisition, including the establishment of a national consumer care sales team.

MORE… “OTC products are a fast developing part of the health care market, one which is characterised by increasing consumer interest in overall health and self-medication. This is a good opportunity for our products.”

Bayer HealthCare Consumer Care is now present in more than 120 countries and the acquisition has made the division a leader in Europe, has extended its top position in Latin America and has reinforced the company’s business in US and Asia-Pacific. Key Bayer consumer care brands in New Zealand are Aspirin®, Canesten®, Alka Seltzer®, Am-O-Lin® baby care products and the Pluravit® vitamin range.

Main Roche brands in New Zealand that are becoming part of the Bayer range are vitamins Berocca®, Supradyn®, Redoxon® and Elevit®, as well as brands Aspro®, Naprogesic®, Cepacol®, Bepanthen® and Ungvita®.

Bayer AG is a German based company with three core business areas – HealthCare, CropScience and MaterialScience. In New Zealand it operates through Bayer New Zealand Ltd, based on Auckland’s North Shore.

For more information: www.bayer.co.nz

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Elsewhere:


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>